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Introduction
Phyllodes tumors of the breast are rare and account for less than 1% of breast tumors. They occur over a wide age range with 
a median age of 45 years. Malignant transformation of a phyllodes tumor is a rare form of breast cancer accounting for just 
0.5% of all breast cancers. A simple mastectomy is performed for giant phyllodes tumors (>10 cm), those that are multifocal, 
in cases of malignant phyllodes tumors, in cases of recurrence or in phyllodes of ‘borderline’ histology 
Case report
We report a rare case of a rapidly growing malignant giant phyllodes tumor of the young, 26 year-old white woman, who 
underwent successful combined treatment nipple-sparing mastectomy and irradiation in National Cancer Institute, Vilnius, 
Lithuania
Conclusions
Multidisciplinary approach and modern imaging studies allows us to diagnose and successfully treat this rare pathological 
state. Scientific trials to delineate proper indications for combined treatment malignant phyllodes tumor of the young pa-
tients are needed. 
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Įvadas
Krūties filoidiniai navikai yra reta patologinė būklė, sudaranti mažiau negu 1 % krūties navikų. Filoidiniai navikai pasitaiko 
įvairaus amžiaus moterims, amžiaus vidurkis yra 45 metai. Filoidinių navikų malignizacija pasitaiko retai ir sudaro 0,5 % visų 
krūties navikų. Paprastoji mastektomija rekomenduojama esant gigantiniams filoidiniams navikams (>10 cm), navikų daugia-
židiniškumui, ligos atsinaujinimui ir histologiškai patvirtintam paribiniam filoidiniam navikui.
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Klinikinis atvejis 
Aprašome retą piktybinio filoidinio naviko atvejį 26 metų moteriai, kuri sėkmingai gydyta Nacionaliniame vėžio institute Vil-
niuje, derinant spenelį tausojančią mastektomiją ir aktinoterapiją. 
Išvados
Daugiadalykis atvejo aptarimas ir modernūs tyrimo metodai leidžia diagnozuoti ir sėkmingai gydyti šią retą patologiją. Reika-
lingi tolesni piktybiniais filoidiniais navikais sergančių jaunų pacienčių moksliniai tyrimai, naujos sudėtinio gydymo indikaci-
jos ir gydymo standartai. 
Reikšminiai žodžiai: piktybiniai filoidiniai krūties navikai, sudėtinis gydymas, spenelį tausojanti mastektomija
Introduction 
In 1838, Müller applied the term cystosarcoma phyl-
lodes and described the leaf-like projection of the stroma 
into cystic spaces. The scientists used term sarcoma due 
to the sarcoma-like macroscopic findings of this tumor 
rather than to indicate its malignant potential [1]. 
Phyllodes tumors of the breast constitute fibroepithelial 
neoplasms that have a morphological resemblance to 
the intracanalicular fibroadenoma at the benign end 
of the spectrum, but with increased stromal cellularity 
and leaf-like architecture [2]. In 1931, Lee and Pack 
reported the first case of metastatic phyllodes tumor. 
[3]. In 1981, World Health Organization (WHO) pre-
sented classification of tumors of the breast, introduced 
the term phyllodes tumors (PT), criteria for diagnosis 
and grading of PT. According WHO PT classifies into 
benign, borderline and malignant grade categories based 
on a followings histological parameters: the degree of 
stromal cellularity and atypia, mitotic count, stromal 
overgrowth, and the nature of their tumor borders. [4]. 
A malignant PT shows marked stromal cellularity and 
atypia, has permeated margins, and has mitotic activity 
of at least 10/10 HPFs [2]. The size of the tumor in 
relation to the breast appears important as this usu-
ally determines the extent of surgery and the resulting 
specimen resection margins. Breast-conserving surgery 
not recommended in large multifocal PT because of 
the risk of inadequate local excision and associated high 
local recurrence [5].
Case presentation
A 26-year-old white woman complained of a rap-
idly growing mass in her right breast over a period 
of 12 months. The patient noticed as a small painless 
lump in the upper-outer quadrant of her breast. In last 
6 months tumor rapidly increased in size, breast became 
swollen, inflamed. She had no family history of breast 
or ovarian cancer.
Her right breast was extremely large and heavy. On 
physical examination, she had a large mass measuring 
19 cm × 18 cm involving the entire left breast with two 
areas of skin deepithelization measuring 11 mm × 8 mm 
and 7 mm × 4 mm (Figure 1). The whole breast moved 
freely over the muscle pectoralis major and there were 
no palpable axillary or supraclavicular lymph nodes. Her 
left breast was normal on palpation.
Breast ultrasound examination revealed a large hetero-
geneous solid mass with internal vascularity replacing left 
breast tissue. The size was difcult to define on ultrasonog-
raphy due to its large size. Breast tumor was without signs 
of invasion to the chest wall and to the axillary, supracla-
vicular and infraclavicular lymph nodes. Ultrasound of the 
abdomen without pathology. Due to the large size of the 
tumor, we did not perform mammography.
Figure 1. Pre-operative view of the tumor 
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Figure 2. Chest CT scan
Figure 5. Macroscopic view of removed tumor 
Figure 3. Nipple-sparing mastectomy: dissection 
Figure 4. Nipple-sparing mastectomy after completion
Chest and abdominal CT scan with ultravist 300 ex-
amination: right breast dimensions 174 mm × 123 mm × 
166 mm round shape, well-defined margins, hetero-
geneous internal structure, consisting of lobules with 
blood perfusion and cavities of tissue destruction. Tumor 
without signs of invasion to the chest wall and axillary, 
supraclavicular and infraclavicular lymph nodes. Chest 
and abdomen CT scan – without pathology (Figure 2). 
Differentiate with tumor phyllodes and angiosarcoma. 
We performed fine needle aspiration of the tumor 
and evacuated 75 ml of yellow fluid, small amount of 
lymphocytes on cytological examination.
Multidisciplinary team decision: nipple-sparing 
mastectomy (in case of free margins) with adjuvant 
radiotherapy 
Surgical treatment. Patient underwent nipple-sparing 
mastectomy, removing breast with tumor with 1–2 cm 
circle margin of normal- appearing breast tissues (Fig. 3 
and 4). Urgent retroareolar and margins pathologic 
(frozen section) examination did not revealed tumor. 
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of normal-appearing breast tissue), and mastectomy 
[12]. Wide excision with a clear surgical margin is the 
preferred therapy for PT. A clear surgical margin is the 
only proven protective factor [13]. Contraindications 
for breast-conserving surgery include large tumors, 
multifocality, and malignancy because of their greater 
risk of recurrence [14]. Mastectomy for or malignant 
PT recommended in cases of giant tumors, if free 
margin cannot be achieved, or in cases of local tu-
mor recurrence [15]. Nipple-sparing mastectomy for 
surgical management of giant malignant PT is rarely 
performed. Histological type is the most important 
predictor for metastatic spread, although it may not 
correlate with clinical behavior because both malignant 
and borderline tumors are capable of metastasizing. 
Stromal overgrowth, occurring in 29% of cases, was 
the only predictor of distant failure in multivariate 
analysis. With malignant tumors, 22% may give rise 
to haematogenous metastasis [14]. The risk of local 
recurrence increases in incompletely excised lesions. 
[10]. Using pooled cancer registry data, Vorherr et al 
estimated an overall five year survival rate of 80% for 
malignant PT [11]. The five-year survival for benign, 
borderline or malignant tumors is of 95.7% for benign 
tumors, 73.7% for borderline tumors, and 66.1% for 
malignant tumors [10]. Since the PT spread through 
Post-operative period was without complication. Fig. 5 
illustrates macroscopic view of removed tumor.
Final pathological examination – malignant phyl-
lodes tumor (18 cm). 54 Gy were realized in 27 fractions 
of post-operative radiotherapy
Discussion
PT is rare breast neoplasm constituting from 0.3% to 
0.9% of all breast tumors. According to Bernstein, the 
incidence of PT is 2.1 per one million people and usu-
ally PTs are benign. They occur over a wide age range 
with a median age of 45 years [7, 8]. The World Health 
Organization classified PTs into three subtypes: benign, 
borderline and malignant, according to the degree of 
stromal cell atypia, stromal overgrowth, the status of 
mitosis and the tumor margin [9]. The median size of 
PT is around 4 cm. Twenty percent of PT grows larger 
than 10 cm [10]. According to McDaniel and Crichlow, 
no more than 700 cases had been reported with tumor 
when they published their article in 1986 [7, 8] (Table).
Surgery is the standard initial treatment option for 
malignant PT. Tumor size is an important factor in 
predicting effect of local treatment [11]. The main 
options of local PT treatment are breast preserv-
ing operation with excision of normal breast tissue 
around the tumor (to obtain of at least a 1 cm margin 
Table. Patient age, tumor diameter, histological types from all studies of PT with greater than 20 patients published 1975–1986
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the bloodstream, the lymph node metastases rates are 
very low (<5%). Thus, axillary dissection is unneces-
sary during the initial surgical intervention [10, 11, 
12]. Radiotherapy is recommended for individuals 
with a high local recurrence risk. Chemotherapy is 
used to treat patients with a high systemic metastatic 
risk. The real role of adjuvant irradiation and chemo-
therapy is undefined and should be tested in prospec-
tive, randomized trials [10, 11, 12, 15, 16].
Our patient 11 months after operation is healthy and 
without signs of local progression or dissemination. Ac-
cording to data, presented in our article, nipple-sparing 
mastectomy and irradiation provide an optimal solution 
of wide local tumor control and cosmesis. In agreement 
with patient, breast reconstruction will be done one year 
after surgery, if there will be no signs of local progression 
or dissemination.
Conclusions
Complains on rapidly growing tumor of the breast, may 
be one of the earliest signs of malignant PT in young 
women. It is extremely important early perform stan-
dard clinical exam with full radiologic examination and 
core biopsy. Nipple-sparing mastectomy is rare in surgi-
cal management of giant malignant PT, but it provides 
an optimal solution of wide local tumor control and 
cosmesis. The adjuvant radiotherapy was administered 
in our case, but the real role of adjuvant irradiation and 
chemotherapy is undefined and should be tested in 
prospective, randomized trials.
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